Showing the single result
Molecule : TucatinibManufacturer : Seagen
TUKYSA® (tucatinib) is an FDA-approved oral medication used to treat adults with certain types of HER2-positive metastatic breast cancer and HER2-positive, RAS wild-type metastatic colorectal cancer. It is a tyrosine kinase inhibitor (TKI) that targets HER2 protein signaling inside cancer cells, offering patients a well-tolerated and effective non-chemotherapy option — including those with brain metastases.